Nitric oxide synthases and heart failure - lessons from genetically manipulated mice

Journal of UOEH

Volumn 35, Issue 2, 2013, Pages 147-158

  Shibata, Kiyoko ^a   Shimokawa, Hiroaki ^b   Yanagihara, Nobuyuki ^a   Otsuji, Yutaka ^a   Tsutsui, Masato ^c  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Heart failure; Left ventricular hypertrophy; Mice; Nitric oxide synthase

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE;

ANIMAL; ARTICLE; DIASTOLIC HEART FAILURE; DISEASE MODEL; ENZYMOLOGY; GENETICS; HEART FAILURE; KNOCKOUT MOUSE; MOUSE; PHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; HEART FAILURE; HEART FAILURE, DIASTOLIC; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III;

EID: 84883881613     PISSN: 0387821X     EISSN: None     Source Type: Journal    
DOI: 10.7888/juoeh.35.147     Document Type: Article

References (67)

1. Bredt DS & Snyder SH (1994): Nitric oxide: a physiological messenger molecule. Annu Rev Biochem 63: 175-195
2. Furchgott RF (1984): The role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol 24: 175-197
3. Ignarro LJ (1990): Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 30: 535-560
4. Moncada S, Palmer RMJ & Higgs EA (1991): Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142
5. Murad F (1997): What are the molecular mechanisms for the antiproliferative effects of nitric oxide and cGMP in vascular smooth muscle? Circulation 95: 1101-1103
6. Shimokawa H (1999): Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol 31: 23-37
7. Dudzinski DM, Igarashi J, Greif D & Michel T (2006): The regulation and pharmacology of endothelial nitric oxide synthase. Annu Rev Pharmacol Toxicol 46: 235-276
8. Forstermann U, Boissel JP & Kleinert H (1998): Expressional control of the "constitutive" isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 12: 773-790
9. Nakata S, Tsutsui M, Shimokawa H et al (2005): Vascular neuronal NO synthase is selectively upregulated by platelet-derived growth factor. Arterioscler Thromb Vasc Biol 25: 2502-2508
10. Nakata S, Tsutsui M, Shimokawa H et al (2007): Statin treatment upregulates vascular neuronal nitric oxide synthase through Akt/NF-kappaB pathway. Arterioscler Thromb Vasc Biol 27: 92-98
11. Tsutsui M (2004): Neuronal nitric oxide synthase as a novel anti-atherogenic factor. J Atheroscler Thromb 11: 41-48
12. Buchwalow IB, Podzuweit T, Bocker W, Samoilova VE, Thomas S, Wellner M, Baba HA, Robenek H, Schnekenburger J & Lerch MM (2002): Vascular smooth muscle and nitric oxide synthase. FASEB J 16: 500-508
13. Park CS, Park R & Krishna G (1996): Constitutive expression and structural diversity of inducible isoform of nitric oxide synthase in human tissues. Life Sci 59: 219-225
14. Godecke A, Decking UK, Ding Z, Hirchenhain J, Bidmon HJ, Godecke S & Schrader J (1998): Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res 82: 186-94
15. Gyurko R, Leupen S & Huang PL (2002): Deletion of exon 6 of the neuronal nitric oxide synthase gene in mice results in hypogonadism and infertility. Endocrinology 143: 2767-2774
16. Huang PL, Dawson TM, Bredt DS, Snyder SH & Fishman MC (1993): Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75: 1273-1286
17. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA & Fishman MC (1995): Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242
18. Laubach VE, Shesely EG, Smithies O & Sherman PA (1995): Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A 92: 10688-10692
19. MacMicking JD, Nathan C, Hom G et al (1995): Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641-650
20. Morishita T, Tsutsui M, Shimokawa H et al (2005): Nephrogenic diabetes insipidus in mice lacking all nitric oxide synthase isoforms. Proc Natl Acad Sci U S A 102: 10616-10621
21. Packer MA, Stasiv Y, Benraiss A, Chmielnicki E, Grinberg A, Westphal H, Goldman SA & Enikolopov G (2003): Nitric oxide negatively regulates mammalian adult neurogenesis. Proc Natl Acad Sci U S A 100: 9566-9571
22. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC & Smithies O (1996): Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 93: 13176-13181
23. Son H, Hawkins RD, Martin K, Kiebler M, Huang PL, Fishman MC & Kandel ER (1996): Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell 87: 1015-1023
24. Tranguch S & Huet-Hudson Y (2003): Decreased viability of nitric oxide synthase double knockout mice. Mol Reprod Dev 65: 175-179
25. Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S & Liew FY (1995): Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375: 408-411
26. Brunner F, Andrew P, Wolkart G, Zechner R & Mayer B (2001): Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Circulation 104: 3097-3102
27. Burkard N, Rokita AG, Kaufmann SG et al (2007): Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility. Circ Res 100: e32-e44
28. Heger J, Godecke A, Flogel U, Merx MW, Molojavyi A, Kuhn-Velten WN & Schrader J (2002): Cardiacspecific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction. Circ Res 90: 93-99
29. Janssens S, Pokreisz P, Schoonjans L et al (2004): Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circ Res 94: 1256-1262
30. Loyer X, Gomez AM, Milliez P et al (2008): Cardiomyocyte overexpression of neuronal nitric oxide synthase delays transition toward heart failure in response to pressure overload by preserving calcium cycling. Circulation 117: 3187-3198
31. Mungrue IN, Gros R, You X, Pirani A, Azad A, Csont T, Schulz R, Butany J, Stewart DJ & Husain M (2002): Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J Clin Invest 109: 735-743
32. Ohashi Y, Kawashima S, Hirata K, Yamashita T, Ishida T, Inoue N, Sakoda T, Kurihara H, Yazaki Y & Yokoyama M (1998): Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J Clin Invest 102: 2061-2071
33. Packer MA, Hemish J, Mignone JL, John S, Pugach I & Enikolopov G (2005): Transgenic mice overexpressing nNOS in the adult nervous system. Cell Mol Biol (Noisy-le-grand) 51: 269-277
34. Takamura T, Kato I, Kimura N, Nakazawa T, Yonekura H, Takasawa S & Okamoto H (1998): Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis. J Biol Chem 273: 2493-2496
35. Van Haperen R, de Waard M, van Deel E, Mees B, Kutryk M, van Aken T, Hamming J, Grosveld F, Duncker DJ & de Crom R (2002): Reduction of blood pressure, plasma cholesterol, and atherosclerosis by elevated endothelial nitric oxide. J Biol Chem 277: 48803-48807
36. Jones SP, Greer JJ, van Haperen R, Duncker DJ, de Crom R & Lefer DJ (2003): Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice. Proc Natl Acad Sci U S A 100: 4891-4896
37. Scherrer-Crosbie M, Ullrich R, Bloch KD et al (2001): Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 104: 1286-1291
38. Ichinose F, Bloch KD, Wu JC, Hataishi R, Aretz HT, Picard MH & Scherrer-Crosbie M (2004): Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency. Am J Physiol Heart Circ Physiol 286: H1070-H1075
39. Landmesser U, Engberding N, Bahlmann FH et al (2004): Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation 110: 1933-1939
40. Liu YH, Xu J, Yang XP, Yang F, Shesely E & Carretero OA (2002): Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure. Hypertension 39: 375-381
41. Hafezi-Moghadam A, Simoncini T, Yang Z et al (2002): Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 8: 473-479
42. Massion PB & Balligand JL (2003): Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice. J Physiol 546: 63-75
43. Prabhu SD (2004): Nitric oxide protects against pathological ventricular remodeling: reconsideration of the role of NO in the failing heart. Circ Res 94: 1155-1157
44. Dawson D, Lygate CA, Zhang MH, Hulbert K, Neubauer S & Casadei B (2005): nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation 112: 3729-3737
45. Saraiva RM, Minhas KM, Raju SV, Barouch LA, Pitz E, Schuleri KH, Vandegaer K, Li D & Hare JM (2005): Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: role of nitroso-redox equilibrium. Circulation 112: 3415-3422
46. Casadei B (2006): The emerging role of neuronal nitric oxide synthase in the regulation of myocardial function. Exp Physiol 91: 943-955
47. Feng Q, Lu X, Jones DL, Shen J & Arnold JM (2001): Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation 104: 700-704
48. Liu YH, Carretero OA, Cingolani OH, Liao TD, Sun Y, Xu J, Li LY, Pagano PJ, Yang JJ & Yang XP (2005): Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction. Am J Physiol Heart Circ Physiol 289: H2616-H2623
49. Sam F, Sawyer DB, Xie Z, Chang DL, Ngoy S, Brenner DA, Siwik DA, Singh K, Apstein CS & Colucci WS (2001): Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction. Circ Res 89: 351-356
50. Zhang P, Xu X, Hu X, van Deel ED, Zhu G & Chen Y (2007): Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure. Circ Res 100: 1089-1098
51. Mungrue IN, Husain M & Stewart DJ (2002): The role of NOS in heart failure: lessons from murine genetic models. Heart Fail Rev 7: 407-422
52. Saraiva RM & Hare JM (2006): Nitric oxide signaling in the cardiovascular system: implications for heart failure. Curr Opin Cardiol 21: 221-228
53. Suda O, Tsutsui M, Morishita T, Tanimoto A, Horiuchi M, Tasaki H, Huang PL, Sasaguri Y, Yanagihara N & Nakashima Y (2002): Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice. Circulation 106: 1729-1735
54. Suda O, Tsutsui M, Morishita T et al (2004): Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice. Arterioscler Thromb Vasc Biol 24: 1682-1688
55. Tsutsui M, Shimokawa H, Morishita T, Nakashima Y & Yanagihara N (2006): Development of genetically engineered mice lacking all three nitric oxide synthases. J Pharmacol Sci 102: 147-154
56. Nakata S, Tsutsui M, Shimokawa H et al (2008): Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms. Circulation 117: 2211-2223
57. Tsutsui M, Nakata S, Shimokawa H, Otsuji Y & Yanagihara N (2008): Spontaneous myocardial infarction and nitric oxide synthase. Trends Cardiovasc Med 18: 275-279
58. Shibata K, Yatera Y, Furuno Y et al (2010): Spontaneous development of left ventricular hypertrophy and diastolic dysfunction in mice lacking all nitric oxide synthases. Circ J 74: 2681-2692
59. Ho KK, Pinsky JL, Kannel WB & Levy D (1993): The epidemiology of heart failure: the Framingham Stud. J Am Coll Cardiol 22: 6A-13A
60. Yamamoto K, Sakata Y, Ohtani T, Takeda Y & Mano T (2009): Heart failure with preserved ejection fraction. Circ J 73: 404-410
61. Zile MR & Brutsaert DL (2002): New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 105: 1387-1393
62. Buys ES, Sips P, Vermeersch P, Raher MJ, Rogge E, Ichinose F, Dewerchin M, Bloch KD, Janssens S & Brouckaert P (2008): Gender-specific hypertension and responsiveness to nitric oxide in sGCalpha1 knockout mice. Cardiovasc Res 79: 179-186
63. Du XJ, Samuel CS, Gao XM, Zhao L, Parry LJ & Tregear GW (2003): Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype. Cardiovasc Res 57: 395-404
64. Silberman GA, Fan TH, Liu H et al (2010): Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction. Circulation 121: 519-528
65. Abraham TP, Jones M, Kazmierczak K, Liang HY, Pinheiro AC, Wagg CS, Lopaschuk GD & Szczesna-Cordary D (2009): Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice. Cardiovasc Res 82: 84-92
66. Calderone A, Thaik CM, Takahashi N, Chang DL & Colucci WS (1998): Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest 101: 812-818
67. Paulus WJ, Vantrimpont PJ & Shah AM (1994): Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation 89: 2070-2078